Everett Stone

Technologies

• Human enzyme-mediated depletion of serine in cancer
• Engineered enzymes for cystinuria treatment
• Pharmacologically optimized human kynureninase variants for cancer treatment
• Therapeutic applications of engineered L-Cyst(e)ine-degrading enzymes
• Engineered enzymes for treating cancer and severe combined immunodeficiency
• Engineered enzymes for enhanced kynurenine degradation in cancer therapy​​
• Enhanced cancer treatment through methionine depletion
• Biotechnological approach for cancer treatment through kynurenine depletion using engineered enzymes​​​​​
• Biotechnological platform for engineering enzymes to degrade L‑Cyst(e)ine for cancer therapy
• Improved Human Methylthioadenosine/Adenosine (MTA/ADO) Depleting Enzyme Variants for Cancer Therapy
• Modified kynureninase enzymes for cancer therapy